Ige025
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
245 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Asthma | D001249 | EFO_0000270 | J45 | 5 | 15 | 25 | 37 | 30 | 107 |
| Chronic urticaria | D000080223 | — | L50.8 | 3 | 10 | 18 | 5 | 6 | 40 |
| Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 3 | 16 | 2 | 1 | 7 | 26 |
| Urticaria | D014581 | EFO_0005531 | L50 | 4 | 5 | 5 | 3 | 5 | 20 |
| Food hypersensitivity | D005512 | EFO_1001890 | — | 3 | 11 | — | 4 | 3 | 19 |
| Nasal polyps | D009298 | — | J33 | 1 | 2 | 3 | 3 | 4 | 13 |
| Healthy volunteers/patients | — | — | — | 8 | — | — | 1 | — | 9 |
| Atopic dermatitis | D003876 | EFO_0000274 | L20 | 2 | 1 | — | 3 | 3 | 9 |
| Allergic rhinitis | D065631 | — | J30.9 | 2 | — | — | 2 | 4 | 8 |
| Anaphylaxis | D000707 | — | T78.2 | — | 1 | — | 1 | 3 | 5 |
Show 14 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Peanut hypersensitivity | D021183 | EFO_0007425 | — | 3 | 7 | 1 | — | — | 8 |
| Immune system diseases | D007154 | — | D89.9 | 3 | — | 1 | — | — | 4 |
| Allergic rhinitis seasonal | D006255 | EFO_0003956 | J30 | — | 1 | 1 | — | 2 | 4 |
| Pruritus | D011537 | — | L29 | — | — | 1 | — | — | 1 |
| Bronchitis | D001991 | — | J40 | — | 1 | 1 | — | — | 1 |
| Acute disease | D000208 | — | — | — | 1 | 1 | — | — | 1 |
| Mastocytosis | D008415 | — | D47.09 | — | 1 | 1 | — | — | 1 |
| Interstitial cystitis | D018856 | EFO_1000869 | N30.1 | — | — | 1 | — | — | 1 |
| Dyspnea | D004417 | — | R06.0 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cold urticaria | D000096703 | — | — | 1 | 1 | — | — | — | 2 |
| Eosinophilic esophagitis | D057765 | EFO_0004232 | K20.0 | 1 | 1 | — | — | — | 2 |
| Esophagitis | D004941 | HP_0100633 | K20 | 1 | 1 | — | — | — | 2 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | 2 | — | — | — | 2 |
| Immunotherapy | D007167 | — | — | — | 1 | — | — | 1 | 2 |
| Milk hypersensitivity | D016269 | EFO_0007369 | — | 1 | 1 | — | — | — | 2 |
| Female infertility | D007247 | EFO_0008560 | N97 | — | 1 | — | — | — | 1 |
| Bronchiolitis obliterans syndrome | D000092122 | — | D89.811 | — | 1 | — | — | — | 1 |
| Solar urticaria | D000092130 | — | L56.3 | — | 1 | — | — | — | 1 |
| Covid-19 | D000086382 | — | U07.1 | — | 1 | — | — | — | 1 |
Show 10 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dermatitis | D003872 | — | L30.9 | 1 | — | — | — | 1 | 2 |
| Autism spectrum disorder | D000067877 | — | F84.0 | 1 | — | — | — | — | 1 |
| Drug hypersensitivity | D004342 | EFO_0009482 | T88.7 | 1 | — | — | — | — | 1 |
| Colonic neoplasms | D003110 | — | C18 | 1 | — | — | — | — | 1 |
| Sjogren's syndrome | D012859 | EFO_0000699 | M35.0 | 1 | — | — | — | — | 1 |
| Systemic lupus erythematosus | D008180 | EFO_0002690 | M32 | 1 | — | — | — | — | 1 |
| Immunologic deficiency syndromes | D007153 | — | D84.9 | 1 | — | — | — | — | 1 |
| Job syndrome | D007589 | EFO_0003775 | D82.4 | 1 | — | — | — | — | 1 |
| Hypereosinophilic syndrome | D017681 | EFO_1001467 | D72.11 | 1 | — | — | — | — | 1 |
| Chronic inducible urticaria | D000094482 | — | L50.4 | 1 | — | — | — | — | 1 |
Show 3 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Emergencies | D004630 | — | — | — | — | — | — | 1 | 1 |
| Herpes simplex | D006561 | — | B00 | — | — | — | — | 1 | 1 |
| Kaposi varicelliform eruption | D007617 | — | B00.0 | — | — | — | — | 1 | 1 |
| Aspergillosis | D001228 | EFO_0007157 | B44 | — | — | — | — | 1 | 1 |
| Pulmonary aspergillosis | D055732 | EFO_1001834 | — | — | — | — | — | 1 | 1 |
| Mycoses | D009181 | — | B35-B49 | — | — | — | — | 1 | 1 |
| Psoriasis | D011565 | EFO_0000676 | L40 | — | — | — | — | 1 | 1 |
| Hidradenitis suppurativa | D017497 | — | L73.2 | — | — | — | — | 1 | 1 |
| Mycosis fungoides | D009182 | — | C84.0 | — | — | — | — | 1 | 1 |
| T-cell lymphoma cutaneous | D016410 | — | C84.A | — | — | — | — | 1 | 1 |
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use